MedPath

Clinical observation for the effect of Ke-Gan-Li-Yan oral liquid on the relief of laryngeal symptoms of novel coronavirus pneumonia (COVID-19) convalescence and suspected patients and other susceptible people

Phase 4
Not yet recruiting
Conditions
ovel Coronavirus Pneumonia (COVID-19)
Pharyngitis, laryngitis
Registration Number
ITMCTR2000003216
Lead Sponsor
The Fifth Affiliated Hospital of Sun Yat-Sen University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. At the time of signing the informed consent, male or female aged 18 to 65 years old;
2. Covid-19 convalescent patients, suspected patients, fever and other susceptible groups with respiratory symptoms of laryngeal discomfort;
3. The TCM syndrome differentiation of pharyngeal discomfort in the above population is as follows: dampness-heat accumulation lung syndrome/wind-heat syndrome/wind-heat invasion lung syndrome/phlegm-heat obstructing lung syndrome/lung-heat blazing syndrome/lung-stomach solid heat syndrome and other TCM syndromes;
4. Subject is informed and voluntarily signs an informed consent and agrees to participate in all visits as required by the study protocol.

Exclusion Criteria

1. The researcher decides that it is not in the best interests of the subject to participate in this study, or there is any situation that the protocol cannot be safely followed;
2. Known allergic reaction or allergic constitution to gramanliyan oral liquid or its components;
3. Have participated in or are participating in other clinical researchers within the past 1 month;
4. Positive pregnancy test during pregnancy or breastfeeding or before medication;
5. Other circumstances considered inappropriate for the study.

Study & Design

Study Type
Observational study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
ew fever, cough, muscle soreness, headache, the time it takes for symptoms to disappear or to subside;Symptom scores;Occurrence of adverse events/reactions;Relief time and rate of symptoms of laryngeal discomfort, sore throat, dry and hot pharynx, and pharyngeal mucosal congestion;
Secondary Outcome Measures
NameTimeMethod
Other symptoms such as fever, cough, muscle soreness, headache, etc.;Incidence of COVID - 19;Novel coronavirus positive rate;
© Copyright 2025. All Rights Reserved by MedPath